Variantyx Raises $36M in Funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Stay updated with breaking news from Haim Neerman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Variantyx, a Framingham firm specializing in advanced genomic testing for rare genetic disorders, reproductive health, and precision oncology, has secured $41.5 million in additional funding to advance its rapidly growing global precision oncology business.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
/PRNewswire/ -- Variantyx, a technology-driven precision medicine company providing advanced genomic testing for the rare genetic disorders, reproductive...